FdaApplication

NDA 215813

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAVYXA HOLDINGS LLC
application_typeNDA
approval_date2022-11-22

Products (4)

ProductActive ingredientStrengthDosage form
DOCETAXELDOCETAXEL160MG/16MLINJECTABLE;INJECTION
DOCIVYXDOCETAXEL80MG/8ML (10MG/ML)SOLUTION;INTRAVENOUS
DOCIVYXDOCETAXEL20MG/2ML (10MG/ML)SOLUTION;INTRAVENOUS
DOCIVYXDOCETAXEL160MG/16ML (10MG/ML)SOLUTION;INTRAVENOUS

4 products